{"name":"Dr. Falk Pharma GmbH","slug":"dr-falk-pharma-gmbh","ticker":"","exchange":"","domain":"drfalkpharmagmbh.com","description":"","hq":"Boulogne-Billancourt","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"High dose TSO","genericName":"High dose TSO","slug":"high-dose-tso","indication":"Cryptococcal meningitis","status":"phase_2"},{"name":"high dose budesonide tablet","genericName":"high dose budesonide tablet","slug":"high-dose-budesonide-tablet","indication":"Other","status":"marketed"},{"name":"Placebo orodispersible tablet twice daily","genericName":"Placebo orodispersible tablet twice daily","slug":"placebo-orodispersible-tablet-twice-daily","indication":"Other","status":"phase_3"},{"name":"low dose budesonide tablet","genericName":"low dose budesonide tablet","slug":"low-dose-budesonide-tablet","indication":"Other","status":"marketed"},{"name":"norUrsodeoxycholic acid","genericName":"norUrsodeoxycholic acid","slug":"norursodeoxycholic-acid","indication":"Primary biliary cholangitis","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"mesalamine granules","genericName":"mesalamine granules","slug":"mesalamine-granules","indication":"Mild to moderate ulcerative colitis","status":"phase_3"}]}],"pipeline":[{"name":"High dose TSO","genericName":"High dose TSO","slug":"high-dose-tso","phase":"phase_2","mechanism":"Treats Cryptococcal meningitis by inhibiting the cell wall synthesis of Cryptococcus neoformans","indications":["Cryptococcal meningitis"],"catalyst":""},{"name":"high dose budesonide tablet","genericName":"high dose budesonide tablet","slug":"high-dose-budesonide-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo orodispersible tablet twice daily","genericName":"Placebo orodispersible tablet twice daily","slug":"placebo-orodispersible-tablet-twice-daily","phase":"phase_3","mechanism":"This drug is a placebo, meaning it has no active therapeutic effect.","indications":[],"catalyst":""},{"name":"low dose budesonide tablet","genericName":"low dose budesonide tablet","slug":"low-dose-budesonide-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"mesalamine granules","genericName":"mesalamine granules","slug":"mesalamine-granules","phase":"phase_3","mechanism":"Mesalamine works by releasing aminosalicylates in the colon to reduce inflammation and prevent symptoms of ulcerative colitis.","indications":["Mild to moderate ulcerative colitis","Moderate to severe ulcerative colitis"],"catalyst":""},{"name":"norUrsodeoxycholic acid","genericName":"norUrsodeoxycholic acid","slug":"norursodeoxycholic-acid","phase":"phase_3","mechanism":"NorUrsodeoxycholic acid is a bile acid that acts as an FXR agonist.","indications":["Primary biliary cholangitis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":6,"phaseCounts":{"phase_2":1,"marketed":2,"phase_3":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}